ACTRN12605000078651已完成3 期
A randomized phase III study to evaluate the effects of Oxpentifyllene as an add on therapy for boys with duchenne muscular dystrophy in improving muscle strength and function.
The Children's Hospital at Westmead0 个研究点目标入组 64 人开始时间: 2005年8月5日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 7 Years 至 18 Years（—）
- 性别
- All
入选标准
- •Duchenne muscular dystrophy, ambulant, stable dose of steroids for 12 months.
排除标准
- •No exclusion criteria
研究者
相似试验
招募中
3 期
A randomized phase III study to evaluate the effectiveness of two different dosing regimens (high dose vs daily) of Prednisone for boys with Duchenne muscular dystrophy in improving muscle strength and function and minimising side effects.Musculoskeletal - Other muscular and skeletal disordersDuchenne muscular dystrophyACTRN12605000075684The Children's Hospital at Westmead140
进行中（未招募）
1 期
Progressive Exercise for Anabolism in Kidney DiseaseACTRN12605000101684Kidney Health Australia50
进行中（未招募）
不适用
Activity, Diet and Blood Pressure TrialCardiovascular - HypertensionHypertensionACTRN12605000090617one200
尚未招募
1 期
A randomised phase III study to evaluate the effects of methotrexate in the treatment of women with an ectopic pregnancy to prevent the need for surgical intervention.Reproductive Health and Childbirth - Fetal medicine and complications of pregnancyEctopic pregnancyACTRN12607000113459Associate Professor George Condous400
终止
3 期
A randomised phase III study to evaluate the effectiveness prednisolone therapy for late stage Duchenne muscular dystrophy in maintaining lung functioMusculoskeletal - Other muscular and skeletal disordersDuchenne muscular dystrophyACTRN12605000076673The Children's Hospital at Westmead40